Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

News

Archive

Resolve Therapeutics to present at International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS) Abu Dhabi Investment Office partners with Glydways to bring transformative autonomous transit technology Zeotap awarded ISO 27001 Certification for Information Security Management Ventyx Biosciences announces positive topline results from Phase 2 study of VTX3232 in participants with obesity and cardiovascular risk factors INTRATOMICS and UK’s Paragraf sign MoU to pioneer next-generation Graphene-Based Sensor Technologies PlanetiQ wins $24.3M NOAA contract, largest commercial satellite weather data award ever
Back To News
Conor Medsystems
October 17, 2017

Conor Medsystems

Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.

Cookie Policy Website powered by 100% renewable energy Privacy Policy